{"database":"MassIVE","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://massive-ftp.ucsd.edu/v04/MSV000090331/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"submitter":["Yi-Ting Chen"],"full_dataset_link":["https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=4db2337fa3d94b42bb58f2a207658194"],"submitter_email":["ytchen@mail.cgu.edu.tw"],"sample_protocol":[""],"repository":["MassIVE"],"file_size":["778"],"ptm_modification":["MS:1002864 - No post-translational-modifications are included in the identified peptides of this dataset"],"data_protocol":[""],"omics_type":["Proteomics"],"instrument_platform":["LTQ Orbitrap"],"species":["Homo Sapiens (ncbitaxon:9606)"],"submitter_affiliation":["Department of Biomedical Sciences, College of Medicine, Chang Gung University"],"description_synonyms":["liquid chromatography tandem mass spectroscopy, LC-MS2, dTAF[[II]]230, TAF[[II]]250, d230, Secretomes, Data Set, LC-MS/MS, TAF200, l(3)84Ab, dTAFII250, BG:DS00004.13, TAFII-250, TAF250/230, EfW1, transitional cell carcinoma of bladder, Cell, urothelial bladder carcinoma, dTAF230, dmTAF[[II]]230, TAFII250, RCB1191, LC/MS/MS, Secretome, dmTAF1, Taf230, p230, Protein, LC-MSMS, urinary bladder urothelial carcinoma, TAF[[II]]250/230, TFIID, BLCA, TAF250, Taf[[II]]250, Taf200, dTAF[[II]]250, TAF[[II]]230, LCMSMS, TFIID TAF250, cel, cell, Protein Secretomes, Taf1p, TAF[II]250, CG17603, TAF[[II]], 5637, dTAF250, bladder transitional cell carcinoma, DmelCG17603, Taf250, SR3-5, liquid chromatography-tandem mass spectroscopy, Protein Secretome, liquid chromatography tandem mass spectrometry, LC-MS-MS., TAF, TAF230, TAF1"],"name_synonyms":["dTAF[[II]]230, TAF[[II]]250, d230, Secretomes, Malignant Neoplasm, determination, Neoplasms, Benign Neoplasm, TAF200, l(3)84Ab, dTAFII250, BG:DS00004.13, Tumor, TAFII-250, TAF250/230, Malignant, EfW1, transitional cell carcinoma of bladder, Cell, urothelial bladder carcinoma, dTAF230, dmTAF[[II]]230, TAFII250, MT, Benign, Secretome, dmTAF1, Taf230, p230, Protein, chemical analysis, urinary bladder urothelial carcinoma, Neoplasm, TAF[[II]]250/230, TFIID, BLCA, TAF250, Taf[[II]]250, Taf200, primary cancer, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, Malignancy, cel, cell, Protein Secretomes, Benign Neoplasms, Taf1p, TAF[II]250, Cancers, CG17603, TAF[[II]], malignant tumor, Malignant Neoplasms, Neoplasias, dTAF250, bladder transitional cell carcinoma, DmelCG17603, TAF1., Taf250, malignant neoplasm, SR3-5, Protein Secretome, Malignancies, assay, TAF, Neoplasia, TAF230, Cancer, Tumors"],"additional_accession":["PXD036764"]},"is_claimable":false,"name":"Secretome analysis of 5 BLCA cancer cell lines","description":"We established the comprehensive secretome dataset of five representative BLCA cell lines including BFTC905, TSGH8301, 5637, MGH-U1 and MGH-U4 by LC-MS/MS.","dates":{},"accession":"MSV000090331","cross_references":{}}